Pon1 is an antioxidant gene involved in the reduction of lipid oxidation that is lower in AD patients but its polymorphism is a risk factor for neurological diseases (Erlich et al., 2006; Paragh et al., 2002; Zhang et al., 2013). This evidence concerns the gene PON1 and nervous system disorder.